Systematic review of the use of honey as a wound dressing OA Moore, LA Smith, F Campbell, K Seers, HJ McQuay, RA Moore BMC complementary and alternative medicine 1, 1-6, 2001 | 360 | 2001 |
Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice RA Moore, OA Moore, S Derry, PM Peloso, AR Gammaitoni, H Wang Annals of the rheumatic diseases 69 (2), 374-379, 2010 | 258 | 2010 |
Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease OA Moore, N Goh, T Corte, H Rouse, O Hennessy, V Thakkar, J Byron, ... Rheumatology 52 (1), 155-160, 2013 | 205 | 2013 |
Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: use of pain intensity and visual analogue scales A Moore, O Moore, H McQuay, D Gavaghan Pain 69 (3), 311-315, 1997 | 184 | 1997 |
N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study V Thakkar, WM Stevens, D Prior, OA Moore, J Byron, D Liew, K Patterson, ... Arthritis research & therapy 14, 1-10, 2012 | 133 | 2012 |
Steroid injection for inferior heel pain: a randomised controlled trial EMA Ball, HMA McKeeman, C Patterson, J Burns, WH Yau, OA Moore, ... Annals of the rheumatic diseases 72 (6), 996-1002, 2013 | 130 | 2013 |
Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease OA Moore, SM Proudman, N Goh, TJ Corte, H Rouse, O Hennessy, ... Clin Exp Rheumatol 33 (4 Suppl 91), S111-6, 2015 | 86 | 2015 |
Does rheumatoid arthritis disease activity correlate with weather conditions? EM Savage, D McCormick, S McDonald, O Moore, M Stevenson, ... Rheumatology international 35, 887-890, 2015 | 49 | 2015 |
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma … C Owen, GS Ngian, K Elford, O Moore, W Stevens, M Nikpour, C Rabusa, ... Clin Exp Rheumatol 34 (Suppl 100), 170-176, 2016 | 48 | 2016 |
Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores RA Moore, OA Moore, S Derry, HJ McQuay Arthritis research & therapy 10, 1-5, 2008 | 45 | 2008 |
TB incidence and characteristics in the remote gulf province of Papua New Guinea: a prospective study GB Cross, K Coles, M Nikpour, OA Moore, J Denholm, ES McBryde, ... BMC infectious diseases 14, 1-10, 2014 | 44 | 2014 |
Single dose oral meloxicam for acute postoperative pain in adults RA Moore, S Derry, HJ McQuay Cochrane Database of Systematic Reviews, 2009 | 32 | 2009 |
Multidisciplinary evaluation in patients with lung disease associated with connective tissue disease A Wells, A Devaraj, EA Renzoni, CP Denton Seminars in respiratory and critical care medicine 40 (02), 184-193, 2019 | 30 | 2019 |
Performance of screening algorithms in systemic sclerosis‐related pulmonary arterial hypertension: a systematic review V Thakkar, WM Stevens, OA Moore, M Nikpour Internal Medicine Journal 43 (7), 751-760, 2013 | 17 | 2013 |
Single dose oral tenoxicam for acute postoperative pain in adults OA Moore, M McIntyre, RA Moore, S Derry, HJ McQuay Cochrane Database of Systematic Reviews, 2009 | 11 | 2009 |
Assessing the evidence of effectiveness of acupuncture for stroke rehabilitation: stepped assessment of likelihood of bias LA Smith, OA Moore, HJ McQuay, A Moore Bandolier, 2001 | 7 | 2001 |
FRI0261 Anti-phospholipid antibodies in systemic sclerosis: Prevalence and clinical correlations KB Morrisroe, WM Stevens, J Byron, V Thakkar, O Moore, S Proudman, ... Annals of the Rheumatic Diseases 71 (Suppl 3), 402-402, 2013 | 4 | 2013 |
S. 4.1 N-terminal pro-brain natriuretic peptide levels predict incident pulmonary arterial hypertension in SSc V Thakkar, W Stevens, D Prior, J Byron, K Patterson, P Hissaria, O Moore, ... Rheumatology 51 (suppl_2), ii8-ii10, 2012 | 4 | 2012 |
Lung disease is the major cause of death in the Australian SSc cohort study W Stevens, V Thakkar, O Moore, J Byron, S Proudman, J Zochling, ... Oxford University Press (OUP), 2012 | 4 | 2012 |
Whose responsibility is it to assess cardiovascular risk in patients with rheumatoid arthritis? A Quinlivan, OA Moore, E Romas, M Nikpour Internal Medicine Journal 44 (1), 2014 | 2 | 2014 |